Gastroenterology
Volume 137, Issue 3 , Pages 986-996, September 2009

ErbB Signaling Is Required for the Proliferative Actions of GLP-2 in the Murine Gut

Department of Medicine, Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto, Ontario, Canada

Received 1 October 2008; accepted 29 May 2009. published online 11 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflicts of interest The authors disclose the following: Dr Drucker is a party, together with the University of Toronto and the University Health Network, in a GLP-2 licensing agreement with NPS Pharmaceuticals Inc. The remaining authors disclose no conflicts.

 Funding Supported in part by an operating grant from CIHR MOP-14799 and from the National Cancer Institute of Canada, grant 017428; by the Canadian Cancer Society; and by a Canada Research Chair in Regulatory Peptides (to D.J.D.).

PII: S0016-5085(09)00905-6

doi:10.1053/j.gastro.2009.05.057

Gastroenterology
Volume 137, Issue 3 , Pages 986-996, September 2009

Article Tools

* Image Usage & Resolution